Judge Orders Florida Stem Cell Clinic To Stop Producing Stem Cell Treatments
Executive Summary
Federal court rules that US Stem Cell in Florida must halt injections of stem cell products until the company obtains licenses from the US FDA to market them and demonstrates compliance with drug GMP requirements. This action follows numerous adverse events associated with these product; several patients experienced vision loss after eye injections.
You may also be interested in...
US FDA’s Stem Cell Clinic Enforcement Takes A Hit With Loss In California Case
Federal judge denies government’s request to permanently enjoin California stem cell clinic from administering unapproved stromal vascular stem cell treatments, concluding they are not ‘drugs’ under the FD&CA. Ruling runs counter to decision in similar case involving a Florida stem cell clinic.
US FDA’s Stem Cell Clinic Enforcement Takes A Hit With Loss In California Case
Federal judge denies government’s request to permanently enjoin California stem cell clinic from administering unapproved stromal vascular stem cell treatments, concluding they are not ‘drugs’ under the FD&CA. The ruling runs counter to a decision in a similar case involving a Florida stem cell clinic.
US FDA Action On Regenerative Medicine May Be Hindered If Court Sides With Stem Cell Clinics
Pew Charitable Trusts calls for FDA to take more aggressive enforcement against regenerative medicine products, but the outcome of a bench trial involving two stem cell clinics may limit what the agency can do.